Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil
Ann. hepatol
; 18(6): 849-854, Nov.-Dec. 2019. ilus, tab
Artigo
em Inglês
| Sec. Est. Saúde SP
| ID: biblio-1025379
Biblioteca responsável:
BR31.1
ABSTRACT
INTRODUCTION AND OBJECTIVES:
Direct antiviral agents (DAAs) including sofosbuvir (SOF), daclatasvir (DCV), simeprevir (SIM) and ombitasvir, paritaprevir and dasabuvir were introduced 2015 in Brazil for treatment of hepatitis C virus (HCV) infection. The aims of this study were to assess effectiveness and safety of HCV treatment with DAA in real-life world in a highly admixed population from Brazil. MATERIALS ANDMETHODS:
All Brazilian reference centers for HCV treatment were invited to take part in a web-based registry, prospectively conducted by the Brazilian Society of Hepatology, to assess outcomes of HCV treatment in Brazil with DAAs. Data to be collected included demographics, disease severity and comorbidities, genotype (GT), viral load, DAA regimens, treatment side effects and sustained virological response (SVR).RESULTS:
3939 patients (60% males, mean age 58±10 years) throughout the country were evaluated. Most had advanced fibrosis or cirrhosis, GT1 and were treated with SOF/DCV or SOF/SIM. Overall SVR rates were higher than 95%. Subjects with decompensated cirrhosis, GT2 and GT3 have lower SVR rates of 85%, 90% and 91%, respectively. Cirrhosis and decompensated cirrhosis in GT1 and male sex and decompensated cirrhosis in GT3 were significantly associated with no SVR. Adverse events (AD) and serious AD occurred in 18% and 5% of those subjects, respectively, but less than 1% of patients required treatment discontinuation.CONCLUSION:
SOF-based DAA regimens are effective and safe in the heterogeneous highly admixed Brazilian population and could remain an option for HCV treatment at least in low-income countries
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Brasil
Base de dados:
Sec. Est. Saúde SP
Assunto principal:
Hepatite C
Limite:
Feminino
/
Humanos
/
Masculino
País/Região como assunto:
América do Sul
/
Brasil
Idioma:
Inglês
Revista:
Ann. hepatol
Ano de publicação:
2019
Tipo de documento:
Artigo
Instituição/País de afiliação:
Ambulatorio de Hepatites Virais da Prefeitura Municipal de Criciuma/BR
/
CTA-sae ambulatório hepatites virais/BR
/
Centro de Referência em Especialidades Central/BR
/
Fundação Hospital Estadual do Acre/BR
/
Hospital Albert Einstein/BR
/
Hospital Português/BR
/
Hospital de Base do Distrito Federal/BR
/
Instituto de Neurologia de Curitiba/BR
/
Prefeitura de Feira de Santana/BR
/
Secretaria de Estado da Saúde. São Paulo/BR